WASHINGTON -(Dow Jones)- Federal regulators warned Bayer AG (BAYRY) for significant manufacturing deviations found at a company plant in Germany and said some batches of the ingredients used in the company's oral contraceptive pills, Yaz and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA: Some Batches Of Bayer Drugs Shouldn't Have Been Released
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account